Trial Profile
Efficacy and safety of a 4 year pubertal therapy with growth hormone (somatropine Omnitrope) or an aromatase inhibitor (letrozole Femara) or the combination of both in boys with a short predicted height: The OMNIMARA Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2017
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Somatropin (Primary)
- Indications Short stature
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms OMNIMARA
- 13 Aug 2014 New trial record